Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / NOTE 7.500% 5/0
-
Market price (% of par)
-
174.0%
-
Total 13F principal
-
$30,844,000
-
Principal change
-
+$30,844,000
-
Total reported market value
-
$53,542,000
-
Number of holders
-
7
-
Value change
-
+$53,542,000
-
Number of buys
-
7
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 as of Q4 2014
As of 31 Dec 2014,
SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 was held by
7 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$30,844,000
in principal (par value) of the bond.
The largest 7 bondholders included
Orchard Hill Capital Management LP, ZAZOVE ASSOCIATES LLC, 683 Capital Management, LLC, Tekla Capital Management LLC, Ameriprise Financial Inc, WELLINGTON MANAGEMENT GROUP LLP, and GOLDMAN SACHS GROUP INC.
This page lists
7
institutional bondholders reporting positions
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.